EnPlusOne Biosciences Inc. — Form D/A
EnPlusOne Biosciences Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2024-12-26. The offering totals $12.9M, of which $12.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-26
- Form: D/A
- Accession: 0001946593-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.9M
- Amount sold: $12.9M
- Investors: 6
- Date of first sale: 2023-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460553
Issuer
- Name: EnPlusOne Biosciences Inc.
- CIK: 0001946593
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 313 PLEASANT STREET, WATERTOWN, MA, 02472
- Phone: 6177446739
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Daniel Janse | Director | Watertown, MA |
| Daniel Wiegand | Director | Watertown, MA |
| Daniel Wiegand | Executive Officer | Watertown, MA |
| Andrew Lee | Director | Nashville, TN |
| Paxton Major | Director | Austin, TX |
| Steven Kasok | Director | Watertown, MA |
| Daniel Ahlstedt | Director | Watertown, MA |
| Daniel Ahlstedt | Executive Officer | Watertown, MA |
Other filings by this issuer (2)
More